BALL vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals significant concerns, most notably a weak Piotroski F-Score of 3/9, indicating poor financial health based on fundamental criteria. Despite strong recent earnings growth (YoY +81.1%) and a reasonable forward P/E of 14.44, the company faces liquidity constraints (Quick Ratio: 0.68) and high leverage (Debt/Equity: 1.38). Analysts recommend a 'buy' with a $62.69 target, implying upside, but insider selling and inconsistent earnings beats (0/4 recent quarters) temper optimism. The stock trades above the Graham Number ($34.5) but below intrinsic value ($77.29), suggesting mixed valuation signals.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
BALL vs TSLA: Head-to-Head Comparison
This page compares Ball Corporation (BALL) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.